logo
Select company
Select metric
-10.85%EBITDA Margin
VS
Market
22
Sector
55
Industry
47
History
33
$ 23.84Close
$ 15.28 - $ 23.84 52-Week Range
Ticker Information

Ticker

FLGT

Company Name

FULGENT GENETICS INC

Sector

Healthcare

Industry

Diagnostics & Research

Exchange

NASDAQ

FULGENT GENETICS INC - EBITDA Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FLGT - EBITDA % Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA MarginRevenues
6/30/2025$ -32.9M-10.85%$ 303.22M
3/31/2025$ -21.59M-7.38%$ 292.45M
12/31/2024$ -22.33M-7.88%$ 283.47M
9/30/2024$ -152.04M-54.74%$ 277.76M
6/30/2024$ -124.82M-42.94%$ 290.7M
3/31/2024$ -127.63M-44.39%$ 287.53M
12/31/2023$ -134.12M-46.37%$ 289.21M
9/30/2023$ -24.97M-8.72%$ 286.41M
6/30/2023$ -26.68M-8.68%$ 307.38M
3/31/2023$ 3.41M0.93%$ 364.87M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FULGENT GENETICS INC's latest trailing twelve months (TTM) EBITDA % stands at 47.72%.
  • Over the past 5 years, FULGENT GENETICS INC's average EBITDA % has been 19.32%.
  • The median EBITDA % for FULGENT GENETICS INC during this period was 18.49%
  • FULGENT GENETICS INC reached its highest EBITDA % over the past 5 years at 73.84%.
  • The lowest EBITDA % recorded by FULGENT GENETICS INC in the same timeframe -54.74%

FULGENT GENETICS INC's EBITDA % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDA % Benchmarks
CompanyEBITDA %
CDNA : CAREDX INC 17.71%CSTL : CASTLE BIOSCIENCES INC 9.41%LAB : STANDARD BIOTOOLS INC -62.17%EOLS : EVOLUS INC -12.08%ANGO : ANGIODYNAMICS INC -2.07%DH : DEFINITIVE HEALTHCARE CORP -109.33%LFMD : LIFEMD INC 3.61%PSNL : PERSONALIS INC -98.72%KROS : KEROS THERAPEUTICS INC 13.13%WEAV : WEAVE COMMUNICATIONS INC -6.31%

Definition of EBITDA Margin

[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
EBITDA / Revenues
(=) EBITDA %
EBITDA % for FULGENT GENETICS INC is calculated as follows: EBITDA [ $ 64.48M ] / Revenues [ $ 135.12M ]
(=) EBITDA % [ 47.72% ]

FLGT - EBITDA Margin, Last 5 years

-54.74%

Minimum

Sep 30, 2024

73.84%

Maximum

Sep 30, 2021

19.32%

Average

18.49%

Median

EBITDA % Benchmark Analysis

The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.12% with a standard deviation of 26.88%.
The following table provides additional summary stats:
EBITDA % in the Market:
filtered constituents3.29K
min-75.07%
max97.73%
average16.12%
median14.72%
std26.88%